2024 May ACSoMP recommendations
Report of the Meeting of the WHO Advisory Committee on Safety of Medicinal Products, 13-14 May 2024
Overview
The Advisory Committee on Safety of Medicinal Products (ACSoMP) was established in 2003 to provide independent, authoritative, scientific advice to WHO on medicines safety issues of global or regional concern. ACSoMP is an independent expert advisory body that provides advice to the World Health Organization Director-General on pharmacovigilance policy and issues related to the safety and effectiveness of medicinal products. The 20th ACSoMP meeting was held virtually from 13-14 May 2024. A summary of the presentations and recommendations are provided below. The next ACSoMP meeting will be organized as a joint in-person meeting with the Global Advisory Committee on Vaccine Safety (GACVS) in Geneva and will take place in November 2024.